Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Health & Medicine

Find out more about the latest cancer treatments, clinical trials, cancer prevention and health policy
Showing 12 out of 3432 results

From the language we use to talk about cancer, to the cancer types that receive the most funding, there’s a lot that we don’t realise has been hugely influenced by the past From the language we use to talk about cancer, to the cancer types that receive the most funding, there’s a lot that we don’t realise has been hugely influenced by the past

by Lilly Matson | In depth | 13 October 2022

13 October 2022

A photograph of a mobile mammogram unit.

In this instalment of our Health Inequalities series, we take a look at some of the barriers that can make it harder for some people to access cancer screening. In this instalment of our Health Inequalities series, we take a look at some of the barriers that can make it harder for some people to access cancer screening.

by Julia Cotterill | Analysis | 23 September 2022

23 September 2022

This entry is part 4 of 5 in the series Health inequalities
A photograph of someone holding a test tube in a lab.

We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma. We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.

by Lilly Matson | Analysis | 22 September 2022

22 September 2022

A prostate cancer cell.

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

by Jacob Smith | News | 13 September 2022

13 September 2022

A illustration of T cells, a type of immune cell attacking cancer

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that.  If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

by Jacob Smith | Analysis | 23 August 2022

23 August 2022

A woman sat on a sofa looking into the distance

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it? A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

by Jacob Smith | In depth | 10 August 2022

10 August 2022